Category
Today's News
More News
Medicine Net Update 2025/07/10

Medicine Net Update 2025/07/10

On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

Medicine Net Update 2025/07/10

On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... Can AI Catch What Doctors Miss? ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...